Granulosa Cell Tumor — Trials

Granulosa Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05348356	Nirogacestat in Ovarian Granulosa Cell Tumors	completed	Phase 2	53	SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY	3	Aug 25, 2026	clinicaltrials
NCT00006227	Paclitaxel in Treating Patients With Ovarian Stromal Cancer	completed	Phase 2	31	Gynecologic Oncology GroupNETWORK	2	Mar 5, 2020	clinicaltrials
NCT00748657	Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary	completed	Phase 2	36	National Cancer Institute (NCI)NIH	1	Jul 23, 2019	clinicaltrials

Data updated 22 days agoSource updated Aug 25, 2026source: clinicaltrials